Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4870168
Max Phase: Preclinical
Molecular Formula: C53H83N19O11
Molecular Weight: 1162.37
Molecule Type: Unknown
Associated Items:
ID: ALA4870168
Max Phase: Preclinical
Molecular Formula: C53H83N19O11
Molecular Weight: 1162.37
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)NC(=O)NCCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
Standard InChI: InChI=1S/C53H83N19O11/c1-30(2)26-40(48(81)67-37(13-8-24-62-51(58)59)46(79)69-39(44(55)77)27-31-15-17-33(73)18-16-31)70-47(80)38(14-9-25-63-52(60)72-53(83)64-22-6-5-21-54)68-49(82)41(28-32-29-65-35-11-4-3-10-34(32)35)71-45(78)36(12-7-23-61-50(56)57)66-42(74)19-20-43(75)76/h3-4,10-11,15-18,29-30,36-41,65,73H,5-9,12-14,19-28,54H2,1-2H3,(H2,55,77)(H,66,74)(H,67,81)(H,68,82)(H,69,79)(H,70,80)(H,71,78)(H,75,76)(H4,56,57,61)(H4,58,59,62)(H4,60,63,64,72,83)/t36-,37-,38-,39-,40-,41-/m0/s1
Standard InChI Key: YIFYGPPLHVPKOD-SKGSPYGFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1162.37 | Molecular Weight (Monoisotopic): 1161.6519 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Konieczny A, Conrad M, Ertl FJ, Gleixner J, Gattor AO, Grätz L, Schmidt MF, Neu E, Horn AHC, Wifling D, Gmeiner P, Clark T, Sticht H, Keller M.. (2021) N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding Constants., 64 (22.0): [PMID:34748345] [10.1021/acs.jmedchem.1c01574] |
Source(1):